| ESMCX | FHJUX | ESMCX / FHJUX | |
| Total Expense Ratio | 2.00 | 1.07 | 187% |
| Annual Report Gross Expense Ratio | 2.19 | 1.07 | 205% |
| Fund Existence | 26 years | 12 years | - |
| Gain YTD | 11.601 | 7.645 | 152% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 164M | 977M | 17% |
| Annual Yield % from dividends | 2.81 | 1.76 | 160% |
| Returns for 1 year | -17.62 | 17.72 | -99% |
| Returns for 3 years | 0.93 | 57.79 | 2% |
| Returns for 5 years | -14.00 | 15.00 | -93% |
| Returns for 10 years | 26.07 | 57.35 | 45% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GLVIX | 90.27 | 1.58 | +1.78% |
| Invesco Global Focus R6 | |||
| BMGAX | 26.25 | 0.11 | +0.42% |
| BlackRock Mid-Cap Growth Equity Inv A | |||
| RLBCX | 40.12 | 0.08 | +0.20% |
| American Funds American Balanced R-3 | |||
| VSFAX | 29.61 | -0.10 | -0.34% |
| Federated Hermes MDT Small Cap Value A | |||
| PHLQX | 50.92 | -0.59 | -1.15% |
| PGIM Jennison Health Sciences R6 | |||